Rite Aid Corporation short interest in 2019
In 2019, Rite Aid Corporation's disclosed short interest ran from 10.00% of shares outstanding on 15 Jan 2019 to 26.42% on 31 Dec 2019, a change of +16.42 percentage points. The year's high was 29.83% on 30 Sep 2019 and its low 10.00% on 15 Jan 2019, averaging 22.42% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.52 days on 28 Feb 2019. Full history: Rite Aid Corporation.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 10.00% (15 Jan 2019)
- End of year
- 26.42% (31 Dec 2019)
- Change
- +16.42 pp
- High
- 29.83% (30 Sep 2019)
- Low
- 10.00% (15 Jan 2019)
- Average
- 22.42%
- Highest days to cover
- 14.52 (28 Feb 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 10.00% | 7.82 | 10-Q filed |
| 31 Jan 2019 | 10.44% | 7.63 | |
| 15 Feb 2019 | 11.74% | 10.10 | |
| 28 Feb 2019 | 11.86% | 14.52 | |
| 15 Mar 2019 | 14.33% | 7.84 | |
| 29 Mar 2019 | 15.82% | 13.09 | |
| 15 Apr 2019 | 19.45% | 7.62 | results (8-K) |
| 28 Jun 2019 | 29.58% | 3.48 | 10-K filed, results (8-K) |
| 15 Jul 2019 | 28.90% | 5.15 | 10-Q filed |
| 31 Jul 2019 | 27.49% | 6.29 | |
| 15 Aug 2019 | 25.97% | 6.56 | |
| 30 Aug 2019 | 29.19% | 9.12 | |
| 13 Sep 2019 | 25.38% | 4.51 | |
| 30 Sep 2019 | 29.83% | 3.97 | results (8-K) |
| 15 Oct 2019 | 26.76% | 5.06 | 10-Q filed |
| 31 Oct 2019 | 26.30% | 6.73 | |
| 15 Nov 2019 | 27.17% | 6.36 | |
| 29 Nov 2019 | 25.78% | 11.01 | |
| 13 Dec 2019 | 25.96% | 10.21 | |
| 31 Dec 2019 | 26.42% | 1.00 | results (8-K) |
See also: Rite Aid Corporation's full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.